Health Care, Pharmaceuticals, Biotech
Feb. 7, 2024
Lawsuit filed over recalled Medtronic insulin pumps
The company initiated a recall in October 2019 and replaced the pumps with versions that have more durable black retainer rings. The Food and Drug Administration issued a Class I recall in February 2020.
Medtronic’s insulin pumps have a defect that causes them to deliver too much or not enough insulin to a patient, leading to possible loss of consciousness, seizure or death, according to a lawsuit filed in Los Angeles.
The claims involve the retainer ring that locks the insulin reservoir inside the company’s MiniMed 600 series insulin pumps. Serious injuries and deaths were reported with the use of MiniMed 600 series pumps with clear retai...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In